Correspondence 0001214659-24-019855 from MICROPAC INDUSTRIES INC (MPAD) (CIK 0000065759)
MICROPAC INDUSTRIES INC (MPAD) (CIK 0000065759)
Date: Dec. 2, 2024 · CIK: 0000065759 · Accession: 0001214659-24-019855
AI Filing Summary & Sentiment
File numbers found in text: 000-05109
Show Raw Text
CORRESP
1
filename1.htm
December 2, 2024
VIA EDGAR
U.S. Securities and Exchange Commission
100 F Street, N.E.
Division of Corporation Finance
Office of Manufacturing
Washington, D.C. 20549
Attention: Jenny O’Shanick and Jay Ingram
Re:
MICROPAC INDUSTRIES, INC
Preliminary Merger Information Statement on Schedule 14C
Filed November 12, 2024
File No. 000-05109
Ladies and Gentlemen:
On behalf of Micropac Industries,
Inc. (the “Company”), below is the response of the Company to the comments of the staff of the Division of Corporation Finance
(the “Staff”) of the United States Securities and Exchange Commission (the “Commission”) set forth in the Staff’s
letter, dated November 22, 2024, regarding the Company’s Information Statement on Schedule 14C (the “Information Statement”)
filed with the Commission on November 12, 2024. In connection with this letter, an amendment to the Information Statement (“Amendment
No. 1”) has been submitted to the Commission on the date hereof.
For your convenience, the
Staff’s comments are set forth in bold, followed by responses on behalf of the Company. Unless otherwise indicated, all page references
in the responses set forth below are to the pages of the clean copy of Amendment No. 1. Capitalized terms used but not otherwise
defined herein shall have the meanings assigned to such terms in Amendment No. 1.
Preliminary Merger Information Statement on
Schedule 14C
The Merger
Background of the Merger, page 13
1.
Please expand this section to discuss the following:
· Revise
to specify which party initiated the deal.
· We
note your disclosure on page 14 that the Micropac Board and management considered potential strategic alternatives. Revise to elaborate
on these alternatives and whether the Micropac Board and management pursued these alternate transactions. If not, discuss why. If so,
discuss what factors led the Micropac Board to choose this transaction over any others.
· We
note your disclosure on page 15 that Teledyne’s initial non-binding letter of intent contemplated an all-cash transaction at a purchase
price of $20.00 per share of Micropac Common Stock, which is the same as the final consideration in the executed Merger Agreement. Revise
to discuss how the parties negotiated the material terms of the Merger from the non-binding letter of intent until the execution of the
Merger Agreement. In this regard, discuss what was proposed by one party with respect to the deal value and whether a counteroffer was
made. If there was a counteroffer, discuss how the parties came to an agreement on the final material term.
Haynes and Boone, LLP
2801 N. Hardwood Street | Suite 2300 | Dallas, TX 75201
T: 214.651.5000 | haynesboone.com
U.S. Securities and Exchange Commission
Division of Corporation Finance
Office of Finance
December 2, 2024
Page 2
Response: The Company acknowledges
the Staff’s comment and has revised the disclosure on pages 14-15 of Amendment No. 1.
Opinion of Financial Advisor
General, page 28
2.
Please revise your disclosure to quantify the compensation paid and to be paid to Mesirow for its services related to the Merger. Further, please revise to quantify any fees paid to Mesirow and its affiliates relating to any material relationship that existed during the past two years between you and your affiliates and Mesirow and its affiliates. Refer to Item 1015(b)(4) of Regulation MA.
Response: The Company acknowledges
the Staff’s comment and has revised the disclosure on page 28 of Amendment No. 1.
3.
Refer to page E-3 of Annex E. We note the disclosure that this opinion “may not be relied upon by any other person or entity (including, without limitation, security holders, creditors or other constituents of the Company).” Please have Mesirow provide an updated opinion that eliminates the limitation on reliance. Further, we note the disclosure that this opinion may not be “used for any other purpose without our prior written consent.” Please revise the opinion to confirm whether Mesirow consents to the use of its opinion for your filing.
Response: The Company acknowledges
the Staff’s comment and has revised the disclosure on page E-3 of Amendment No. 1.
* * *
* * *
U.S. Securities and Exchange Commission
Division of Corporation Finance
Office of Finance
December 2, 2024
Page 3
If you have any questions
or require any additional information in connection with the filing, please do not hesitate to contact the undersigned at (214) 651-5443.
Very truly yours,
/s/ Matthew L. Fry
Matthew L. Fry
Haynes and Boone, LLP
cc:
Mark King, Chief Executive Officer
Logan Weissler, Esq., Haynes and Boone, LLP